fda warning bpc-157 not approved safety concerns Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY ⬇️ FDA to review 7 popular

For example, surveys and claims-data show that atorvastatin (a cholesterol-lowering statin) and amlodipine (a blood-pressure calcium-blocker) were the #1 and #2 most prescribed drugs by claims in 2025

If you want to add it for skin, anti-aging, or inflammation support, draw it in

Detailed CoAs were highlighted as a major trust factor

Afyon, S., Krumeich, F

If those compounds reach a cluster of subclinical precancerous cells, the result could be the pharmacological equivalent of pouring accelerant on a fire that was quietly burning at undetectable levels

Specific findings from FDA inspections include failure to monitor cleanroom environments where sterile drugs are prepared, inadequate sterilization of equipment used in drug production, release of a batch of vitamin B6 despite microbial contamination detected in the production room, incomplete cleaning validation for equipment used in compounding implantable pellets, and repeat violations that were identified in previous inspections but not corrected